PREDECT Protocols for Complex 2D/3D Cultures.

Area of Science:

• Biotechnology
• Cancer Research
• Drug Discovery

Background:

• Developing reliable cell culture models is crucial for advancing cancer research and drug discovery.
• Existing models often lack the complexity to accurately mimic in vivo tumor microenvironments.
• Standardized protocols are needed across different laboratories and institutions.

Purpose of the Study:

• To establish robust and versatile 2D and 3D cell culture platforms for drug discovery.
• To create standardized protocols for monoculture and coculture models of increasing complexity.
• To facilitate the transferability of these models across academic, biotech, and pharmaceutical settings.

Main Methods:

• Established protocols for 2D and 3D monoculture and stromal coculture models (spheroid, bioreactor, embedded cultures).
• Utilized three cancer cell lines (MCF7, LNCaP, NCI-H1437) representing breast, prostate, and lung pathologies.
• Employed fluorescent protein-tagged cell lines for online monitoring of growth curves and drug responses.

Main Results:

• Successfully established multiple 2D and 3D culture platforms with increasing complexity.
• Demonstrated the adaptability of these models across different tumor cell lines and pathologies.
• Enabled online measurement of cell growth and drug efficacy through fluorescent tagging.

Conclusions:

• The developed methodologies and detailed protocols support the integration of these advanced models into the drug discovery pipeline.
• These adaptable platforms offer a robust solution for preclinical drug testing and personalized medicine approaches.
• Standardized, complex cell culture models enhance the reliability and efficiency of pharmaceutical research.